James Taylor Vi

M.D. | Pediatric Hematology-Oncology | Male

James Taylor Vi, M.D. is a Washington, District Of Columbia based Pediatric doctor with medical specialization in Pediatric Hematology-Oncology. Current practice location of James Taylor Vi is 2041 Georgia Ave Nw Ste B&c, Washington, District Of Columbia - 20060-0005. He can be contacted on phone at 202-865-3118. James Taylor Vi is a sole proprietor of his business.
NPI number (Unique professional ID) for James Taylor Vi is 1487689295 which was assigned by NPPES on 11 Jul, 2006 and it was last updated on 22 Mar, 2023. James Taylor Vi license number is MD044755 for Pediatrics, Pediatric Hematology-Oncology (2080P0207X) in District Of Columbia.
James Taylor Vi is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
James Taylor Vi basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics, Pediatric Hematology-Oncology
Provider Name :James Taylor Vi
Credential :M.D.
Gender :Male
Business Address:
James Taylor Vi address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :2041 Georgia Ave Nw Ste B&c
Washington, DC, 20060-0005
United States
Phone Number :202-865-3118
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1487689295
NPI Entity Type : Individual
First Enrolment Date : 11 Jul, 2006
Last Updated On : 22 Mar, 2023
Medicare Participation:
James Taylor Vi participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :6800170978
Medicare Enrollment ID :I20170309001388
Primary Specialty :Hematology/oncology
Medical School :Medical College Of Wisconsin
Graduation Year :1995
Accepts Medicare?Yes. James Taylor Vi accepts medicare insurance.
Group Practice Association:
James Taylor Vi is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which James Taylor Vi is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Howard University09411095651322041 Georgia Nw Ave
Washington, DC - 200600001
Ph: 2028656679
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for James Taylor Vi are as mentioned. Primary taxonomy code for James Taylor Vi, M.D. is 2080P0207X (Pediatrics, Pediatric Hematology-Oncology).
Taxonomy Code SpecialityPrimaryLicense No.State
2080P0207XPediatrics, Pediatric Hematology-OncologyYesMD044755DC
208000000XPediatricsNoD58250MD
Legacy Identifiers:
Other legacy medical identifiers of James Taylor Vi such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
411571600MEDICAIDMD
H65418MEDICARE UPINMD
KR40D970MEDICARE ID-Type UnspecifiedMD
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :2041 Georgia Ave Nw Tower 3400
Washington, DC, 20060-0001
United States
Business Location:
Patients can refer following map for directions to James Taylor Vi practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.